Medpace Holdings, Inc. saw a drop in stock price post their second-quarter report, despite positive results. Analysts expect revenue growth and an increase in earnings per share. The consensus price target decreased, indicating mixed opinions on the stock's valuation.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing